The Procter & Gamble Co. (PG/NYSE): general review
09 April 2018, 11:37
| Scenario | |
|---|---|
| Timeframe | Intraday |
| Recommendation | BUY STOP |
| Entry Point | 79.55 |
| Take Profit | 81.00, 82.50, 84.00 |
| Stop Loss | 78.00 |
| Key Levels | 74.50, 76.00, 77.50, 79.50, 83.00, 86.00 |
| Alternative scenario | |
|---|---|
| Recommendation | SELL STOP |
| Entry Point | 77.40 |
| Take Profit | 75.00, 73.00 |
| Stop Loss | 79.00 |
| Key Levels | 74.50, 76.00, 77.50, 79.50, 83.00, 86.00 |
Current trend
Pfizer is in talks with The Procter & Gamble about selling its consumer business, including Chapstick lip balm, Advil analgesic and Centrum vitamins. The two sides split in the financial issue, as The Procter & Gamble estimates the business at USD 15 billion, while Pfizer expects at least USD 20 billion.
On April 20, before the market opens, The Procter & Gamble will publish financial results for Q3 2018.
During the previous week, Procter & Gamble shares decreased by 1.07%. S&P500 index went up by 0.68% during the same period.
Support and resistance
The current technical picture indicates a possible correction of the company's shares after a rather protracted rally. There is a classic reversal formation in the issuer — divergence of price and MACD indicator, for quite a long time. Currently the key trading range is 77.50–79.50. Indicators show mixed signals: the price has consolidated below MA(50) and MA(200), and MACD histogram is in the positive zone. Positions are to be opened from key levels.
Comparing company's multiplier with its competitors, we can say that #PG shares are undervalued.
Support levels: 77.50, 76.00, 74.50.
Resistance levels: 79.50, 83.00, 86.00.
Trading tips
If the price consolidates above the resistance level of 79.50, one should expect the company's shares to correct. Potential profits should be locked in by orders at 81.00, 82.50 and 84.00 Stop-loss will be placed at 78.00.
If the price consolidates below 77.50, sales of #PG should be considered. The movement potential is aimed in the area of 75.00–73.00. Stop-loss should be placed at 79.00.
Implementation period: 3 days.
Pfizer is in talks with The Procter & Gamble about selling its consumer business, including Chapstick lip balm, Advil analgesic and Centrum vitamins. The two sides split in the financial issue, as The Procter & Gamble estimates the business at USD 15 billion, while Pfizer expects at least USD 20 billion.
On April 20, before the market opens, The Procter & Gamble will publish financial results for Q3 2018.
During the previous week, Procter & Gamble shares decreased by 1.07%. S&P500 index went up by 0.68% during the same period.
Support and resistance
The current technical picture indicates a possible correction of the company's shares after a rather protracted rally. There is a classic reversal formation in the issuer — divergence of price and MACD indicator, for quite a long time. Currently the key trading range is 77.50–79.50. Indicators show mixed signals: the price has consolidated below MA(50) and MA(200), and MACD histogram is in the positive zone. Positions are to be opened from key levels.
Comparing company's multiplier with its competitors, we can say that #PG shares are undervalued.
Support levels: 77.50, 76.00, 74.50.
Resistance levels: 79.50, 83.00, 86.00.
Trading tips
If the price consolidates above the resistance level of 79.50, one should expect the company's shares to correct. Potential profits should be locked in by orders at 81.00, 82.50 and 84.00 Stop-loss will be placed at 78.00.
If the price consolidates below 77.50, sales of #PG should be considered. The movement potential is aimed in the area of 75.00–73.00. Stop-loss should be placed at 79.00.
Implementation period: 3 days.
No comments:
Write comments